Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001970684 | SCV002249089 | uncertain significance | Combined immunodeficiency due to OX40 deficiency | 2021-10-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with TNFRSF4-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change affects the initiator methionine of the TNFRSF4 mRNA. The next in-frame methionine is located at codon 52. |